AvDCs (Avibody Drug Conjugates): A Targeted Approach to Efficacy, Improved Tolerability & Favorable PK for Targeted Radio-Therapy, Novel ADC Formats, & Enhanced Tumor Selectivity
Time: 2:10 pm
day: Day One - PM
Details:
- Avibodies are engineered, bivalent mAb fragments, precisely loaded with radiotoxic or cytotoxic payloads
- Sharing pre-clinical data demonstrating traditional ADC, novel pre-targeting, and targeted radio therapy formats
- Biparatopic or bispecific designs against TSEs (Tumor Specific Epitopes) can further enhance solid tumor selectivity